Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions
Clinical trial NCT01131169 · COMPLETED
Trial details
- NCT number
- NCT01131169
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2020-05-15
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.